HEATHER WAUGH: Open Payments
NPI 1457084816 · ENDICOTT, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$441 in 22 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $441
Food & beverage: $441
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $201 |
| Exact Sciences Corporation | 2 | $39 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $38 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| EMD Serono, Inc. | 1 | $22 |
| Alkermes, Inc. | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: VRAYLAR, QULIPTA, The Cologuard Plus Collection Kit, CAPLYTA, LINZESS, AREXVY, VIVITROL, UBRELVY.
Industry payments across NY — which companies pay providers there.
